Back
13
Day Range
$25.10
$25.30
52-Week Range
$23.17
$26.20
Volume
100
50D / 200D Avg
$24.94
/
$25.06
Prev Close
$25.30
Price History
Financial Trends
Peer Comparison
vs Consumer Defensive sector median (329 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 1.0 | 10.4 |
| P/B | 0.2 | 1.2 |
| ROE % | 18.3 | 12.3 |
| Net Margin % | 3.5 | 5.3 |
| Rev Growth 5Y % | 19.7 | 5.6 |
| D/E | 0.6 | 0.6 |
Key Takeaways
Revenue grew 19.69% annually over 5 years — strong growth
ROE of 18.27% — decent returns on equity
Generating 1.77B in free cash flow
P/E of 1.04 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 15.40%
Capital efficient — spends only 2.73% of revenue on capex
Growth
Revenue Growth (5Y)
19.69%
Revenue (1Y)4.29%
Earnings (1Y)2.05%
FCF Growth (3Y)-25.88%
Quality
Return on Equity
18.27%
ROIC12.40%
Net Margin3.47%
Op. Margin5.16%
Safety
Debt / Equity
0.55
Current Ratio1.31
Interest Coverage8.59
Valuation
P/E Ratio
1.04
P/B Ratio0.18
EV/EBITDA1.89
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4.29% | Revenue Growth (3Y) | 9.54% |
| Earnings Growth (1Y) | 2.05% | Earnings Growth (3Y) | 8.95% |
| Revenue Growth (5Y) | 19.69% | Earnings Growth (5Y) | 27.54% |
| Profitability | |||
| Revenue (TTM) | 235.59B | Net Income (TTM) | 8.17B |
| ROE | 18.27% | ROA | 6.76% |
| Gross Margin | 24.48% | Operating Margin | 5.16% |
| Net Margin | 3.47% | Free Cash Flow (TTM) | 1.77B |
| ROIC | 12.40% | FCF Growth (3Y) | -25.88% |
| Safety | |||
| Debt / Equity | 0.55 | Current Ratio | 1.31 |
| Interest Coverage | 8.59 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 1.04 | P/B Ratio | 0.18 |
| P/S Ratio | 0.04 | PEG Ratio | 12.44 |
| EV/EBITDA | 1.89 | Dividend Yield | 0.02% |
| Market Cap | 8.50B | Enterprise Value | 22.94B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 235.59B | 225.91B | 196.34B | 147.14B | 114.80B |
| Net Income | 8.17B | 8.01B | 6.89B | 4.82B | 3.09B |
| EPS (Diluted) | 24.29 | 23.83 | 20.56 | 14.40 | 9.23 |
| Gross Profit | 57.67B | 54.46B | 46.80B | 35.64B | 27.51B |
| Operating Income | 12.15B | 12.02B | 10.16B | 7.08B | 4.92B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 120.96B | 107.67B | 106.64B | 79.57B | 69.21B |
| Total Liabilities | 73.29B | 65.14B | 66.45B | 48.46B | 41.12B |
| Shareholders' Equity | 47.30B | 42.19B | 39.81B | 30.84B | 27.86B |
| Total Debt | 26.21B | 22.35B | 21.99B | 15.19B | 14.12B |
| Cash & Equivalents | 11.77B | 11.72B | 12.40B | 7.40B | 8.12B |
| Current Assets | 56.31B | 52.25B | 53.78B | 39.07B | 31.70B |
| Current Liabilities | 43.00B | 42.29B | 41.67B | 31.74B | 29.61B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#500 of 658
Recent Activity
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026